HERBALIFE LTD. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
HERBALIFE LTD. (HLF) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $11.80 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2026-08-05
- HERBALIFE LTD. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2026-03-31 was $10.26, a 7.65% decline year-over-year.
- HERBALIFE LTD. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2025-03-31 was $11.11, a 37.90% decline year-over-year.
- HERBALIFE LTD. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2024-03-31 was $17.89, a 56.11% decline year-over-year.
- HERBALIFE LTD. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2023-03-31 was $40.76, a 10.24% decline year-over-year.
- HERBALIFE LTD. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2025 was $10.78, a 33.95% decline from fiscal 2024.
- HERBALIFE LTD. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2024 was $16.32, a 47.61% decline from fiscal 2023.
- HERBALIFE LTD. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2023 was $31.15, a 25.55% decline from fiscal 2022.
- HERBALIFE LTD. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2022 was $41.84, a 14.26% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.80 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $10.26 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $10.78 10-K · filed 2026-02-18 | |||
| 2025-09-30 | $10.70 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | $10.85 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | $11.11 10-Q · filed 2025-04-30 | |||
| 2024-12-31 | $16.32 10-K · filed 2025-02-19 | |||
| 2024-09-30 | $14.83 10-Q · filed 2024-10-30 | |||
| 2024-06-30 | $14.68 10-Q · filed 2024-07-31 | |||
| 2024-03-31 | $17.89 10-Q · filed 2024-05-01 | |||
| 2023-12-31 | $31.15 10-K · filed 2024-02-14 | |||
| 2023-09-30 | $25.97 10-Q · filed 2023-11-01 | |||
| 2023-06-30 | $27.92 10-Q · filed 2023-08-02 | |||
| 2023-03-31 | $40.76 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $41.84 10-K · filed 2023-02-14 | |||
| 2022-09-30 | $42.82 10-Q · filed 2022-10-31 | |||
| 2022-06-30 | $43.28 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | $45.41 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | $48.80 10-K · filed 2022-02-23 | |||
| 2021-09-30 | $44.95 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $44.25 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $43.82 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | $43.79 10-K · filed 2021-02-17 | |||
| 2020-09-30 | $43.94 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | $44.58 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | $46.47 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $40.23 10-K · filed 2020-02-18 | |||
| 2019-09-30 | $40.67 10-Q · filed 2019-10-29 | |||
| 2019-06-30 | $40.28 10-Q · filed 2019-08-01 | |||
| 2019-03-31 | $39.50 10-Q · filed 2019-05-02 | |||
| 2018-12-31 | $43.15 10-K · filed 2019-02-19 | |||
| 2018-09-30 | $43.15 10-Q · filed 2018-10-30 | |||
| 2018-06-30 | $43.15 10-Q · filed 2018-08-01 | |||
| 2018-03-31 | $86.30 10-Q · filed 2018-05-03 | |||
| 2012-12-31 | $6.82 10-K/A · filed 2013-12-16 | |||
| 2012-09-30 | $6.82 10-Q · filed 2012-10-29 | |||
| 2012-06-30 | $6.82 10-Q · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |